Controlled release of Doxorubicin embedded in carboxymethyl chitosan nanofibers

References

• Brannon-Peppas, L. (1997). Polymers in controlled drug delivery. Medical Plastic and Biomaterials, 4, 34–45.
   Google Scholar
• Chen, L., Du, Y., & Zeng, X. (2003). Relationships between the molecular structure and moisture-absorption and moisture-retention abilities of carboxymethyl chitosan. Carbohydrate Research, 338, 333–340.10.1016/S0008-6215(02)00462-7
   PubMed Web of Science ®Google Scholar
• Chouhan, R., & Bajpai, A. (2009). Real time in vitro studies of Doxorubicin release from PHEMA nanoparticles. Journal of Nanobiotechnology, 7, 5.10.1186/1477-3155-7-5
   PubMedGoogle Scholar
• Configliacchi, E., Razzano, G., Rizzo, V., & Vigevani, A. (1996). HPLC methods for the determination of bound and free Doxorubicin, and of bound and free galactosamine, in methacrylamide polymer-drug conjugates. Journal of Pharmaceutical and Biomedical Analysis, 15, 123–129.10.1016/0731-7085(96)01825-0
   PubMed Web of Science ®Google Scholar
• Dash, S., Murthy, P. N., Nath, L., & Chowdhury, P. (2010). Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm, 67, 217–223.
   PubMed Web of Science ®Google Scholar
• Driscoll, D. F. (2006). Lipid injectable emulsions: Pharmacopeial and safety issues. Pharmaceutical Research, 23, 1959–1969.10.1007/s11095-006-9092-4
   PubMed Web of Science ®Google Scholar
• Gohel, M., & Panchal, M. (2002). Novel use of similarity factors f 2 and S d for the development of diltiazem HCl modified-release tablets using a 3 2 factorial design. Drug Development and Industrial Pharmacy, 28, 77–87.10.1081/DDC-120001488
   PubMed Web of Science ®Google Scholar
• Golbayani, P. (2009). Formulation of anti – Cancer drug loaded protein nanoparticles (MSc thesis). Tehan University, Tehran.
   Google Scholar
• Hiemenz, P. C., & Lodge, T. P. (2007). Polymer chemistry. Boca Raton, FL: CRC Press.
   Google Scholar
• Honary, S., Jahanshahi, M., Golbayani, P., Ebrahimi, P., & Ghajar, K. (2010). Doxorubicin-loaded albumin nanoparticles: Formulation and characterization. Journal of Nanoscience and Nanotechnology, 10, 7752–7757.10.1166/jnn.2010.2832
   PubMed Web of Science ®Google Scholar
• Huang, H., Pierstorff, E., Osawa, E., & Ho, D. (2007). Active nanodiamond hydrogels for chemotherapeutic delivery. Nano Letters, 7, 3305–3314.10.1021/nl071521o
   PubMed Web of Science ®Google Scholar
• Ignatova, M., Yossifova, L., Gardeva, E., Manolova, N., Toshkova, R., Rashkov, I., & Alexandrov, M. (2011). Antiproliferative activity of nanofibers containing quaternized chitosan and/or Doxorubicin against MCF-7 human breast carcinoma cell line by apoptosis. Journal of Bioactive and Compatible Polymers, 26, 539–551. 0883911511424655
   Web of Science ®Google Scholar
• Manocha, B., & Margaritis, A. (2010). Controlled release of Doxorubicin from Doxorubicin/γ-polyglutamic acid ionic complex. Journal of Nanomaterials, 2010, Article ID 780171, 3309 pp.
   Web of Science ®Google Scholar
• Mete, D., Horzum, N., & Mohamed, G. S. (2016). Controlled release of Doxorubicin from electrospun gelatin nanofibers. Proceedings of the World Congress on Recent Advances in Nanotechnology (RAN’16), Prague, Czech Republic, April 1–2, 2016 Paper No. NDDTE 126. doi:10.11159/nddte16.126
   Google Scholar
• Mourya, V. K., Inamdar, N. N., & Tiwari, A. (2010). Carboxymethyl chitosan and its applications. Advanced Materials Letters, 1, 11–33.10.5185/amlett
   Google Scholar
• Pisano, C., Cecere, S. C., Di Napoli, M., Cavaliere, C., Tambaro, R., Facchini, G., … Pignata, S. (2013). Clinical trials with pegylated liposomal Doxorubicin in the treatment of ovarian cancer. Journal of drug delivery, 2013.
   PubMedGoogle Scholar
• Qi, R., Tian, X. J., Guo, R., Luo, Y., & Shen, M. (2016). Controlled release of Doxorubicin from electrospun MWCNTs/PLGA hybrid nanofibers. Chinese Journal of Polymer Science, 34, 1047–1059.10.1007/s10118-016-1827-z
   Web of Science ®Google Scholar
• Reul, R., Tsapis, N., Hillaireau, H., Sancey, L., Mura, S., Recher, M., … Fattal, E. (2012). Near infrared labeling of PLGA for in vivo imaging of nanoparticles. Polymer Chemistry, 3, 694–702.10.1039/c2py00520d
   Web of Science ®Google Scholar
• Sohofi, N., Tavanai, H., Morshed, M., & Abdolmaleki, A. (2014). Electrospinning of 100% carboxymethyl chitosan nanofibers. Journal of Engineered Fibers and Fabrics, 1, 87–92.
   Google Scholar
• Weiss, R. B. (1992). The anthracyclines: Will we ever find a better Doxorubicin? Seminars in Oncology, 19, 670–686.
   PubMed Web of Science ®Google Scholar
• Yang, Y., Hua, C., & Dong, C.-M. (2009). Synthesis, self-assembly, and in vitro Doxorubicin release behavior of dendron-like/linear/dendron-like poly(ε-caprolactone)-b-poly(ethylene glycol)-b-poly(ε-caprolactone) triblock copolymers. Biomacromolecules, 10, 2310–2318.10.1021/bm900497z
   PubMed Web of Science ®Google Scholar
• Yang, W., Zuo, W. W., Zho, M. F., Yu, H., Chen, Y. M., & Zhang, Y. (2005). Experimental study on relationship between jet instability and formation of beaded fibres during electrospinning. Polymer Engineering & Science, 45, 704–714.
   Web of Science ®Google Scholar
• Yoo, H. S., Oh, J. E., Lee, K. H., & Park, T. G. (1999). Biodegradable nanoparticles containing Doxorubicin-PLGA conjugate for sustained release. Pharmaceutical Research, 16, 1114–1118.10.1023/A:1018908421434
   PubMed Web of Science ®Google Scholar